Literature DB >> 7727543

Altered kinetics of cytochrome c oxidase in a patient with severe mitochondrial encephalomyopathy.

L G Nijtmans1, P G Barth, C R Lincke, M J Van Galen, R Zwart, P Klement, P A Bolhuis, W Ruitenbeek, R J Wanders, C Van den Bogert.   

Abstract

Deficiency of cytochrome c oxidase activity was established in a girl born to consanguineous parents. She showed symptoms of dysmaturity, generalized hypotonia, myoclonic seizures and progressive respiratory failure, leading to death on the seventh day of life. Structural abnormalities of the central nervous system consisted of severe cerebellar hypoplasia and optic nerve atrophy. Biochemical analysis of a muscle biopsy specimen demonstrated deficiency of cytochrome c oxidase activity. Cultured fibroblasts from this patient also showed a selective decrease in the activity of cytochrome c oxidase, excluding a muscle-specific type of deficiency. Further investigations in cultured fibroblasts revealed that synthesis, assembly and stability of both the mitochondrial and the nuclear subunits of the enzyme were entirely normal. The steady-state concentration of cytochrome c oxidase in the fibroblasts of the patient was also normal, suggesting that the kinetic properties of the enzyme were altered. Analysis of the kinetic parameters of cytochrome c oxidase demonstrated an aberrant interaction between cytochrome c oxidase and its substrate, cytochrome c, most likely because of a mutation in one of the nuclear subunits of the enzyme.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7727543     DOI: 10.1016/0925-4439(95)00044-5

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  8 in total

1.  Fatal neonatal liver failure and depletion of mitochondrial DNA in three children of one family.

Authors:  H D Bakker; C Van den Bogert; H R Scholte; R Zwart; F A Wijburg; J N Spelbrink
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

2.  Progressive generalized brain atrophy and infantile spasms associated with cytochrome c oxidase deficiency.

Authors:  H D Bakker; C Van den Bogert; J G Drewes; P G Barth; H R Scholte; R J Wanders; W Ruitenbeek
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

Review 3.  Defects in the mitochondrial energy metabolism outside the respiratory chain and the pyruvate dehydrogenase complex.

Authors:  F J Trijbels; W Ruitenbeek; M Huizing; U Wendel; J A Smeitink; R C Sengers
Journal:  Mol Cell Biochem       Date:  1997-09       Impact factor: 3.396

4.  Simultaneous occurrence of the 11778 (ND4) and the 9438 (COX III) mtDNA mutations in Leber hereditary optic neuropathy: molecular, biochemical, and clinical findings.

Authors:  R J Oostra; C Van den Bogert; L G Nijtmans; M J van Galen; R Zwart; P A Bolhuis; E M Bleeker-Wagemakers
Journal:  Am J Hum Genet       Date:  1995-10       Impact factor: 11.025

Review 5.  Human cytochrome c oxidase: structure, function, and deficiency.

Authors:  J W Taanman
Journal:  J Bioenerg Biomembr       Date:  1997-04       Impact factor: 2.945

6.  Wobble modification defect in tRNA disturbs codon-anticodon interaction in a mitochondrial disease.

Authors:  T Yasukawa; T Suzuki; N Ishii; S Ohta; K Watanabe
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

7.  Defective kinetics of cytochrome c oxidase and alteration of mitochondrial membrane potential in fibroblasts and cytoplasmic hybrid cells with the mutation for myoclonus epilepsy with ragged-red fibres ('MERRF') at position 8344 nt.

Authors:  H Antonická; D Floryk; P Klement; L Stratilová; J Hermanská; H Houstková; M Kalous; Z Drahota; J Zeman; J Houstek
Journal:  Biochem J       Date:  1999-09-15       Impact factor: 3.857

8.  X-linked cardioskeletal myopathy and neutropenia (Barth syndrome): respiratory-chain abnormalities in cultured fibroblasts.

Authors:  P G Barth; C Van den Bogert; P A Bolhuis; H R Scholte; A H van Gennip; R B Schutgens; A G Ketel
Journal:  J Inherit Metab Dis       Date:  1996       Impact factor: 4.982

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.